Eton Pharmaceuticals, Inc. - Common Stock (ETON)

54 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q3 2021.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,962,287 shares of 26,828,643 outstanding shares and own 22.22% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (3,088,100 shares), VANGUARD GROUP INC (866,465 shares), AWM Investment Company, Inc. (500,000 shares), BlackRock Inc. (300,598 shares), GEODE CAPITAL MANAGEMENT, LLC (157,116 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (117,493 shares), Westside Investment Management, Inc. (105,300 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (100,500 shares), STATE STREET CORP (83,772 shares), and GSA CAPITAL PARTNERS LLP (82,314 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.